Metcela Inc. | Revolutionizing the Way We Treat Heart Failure > NEWS > PRESS RELEASE > Metcela Acquires Japan Regenerative Medicine Co., Ltd., Developing Cardiac Stem Cell-based Therapy > 20220404_Metcela_JRM Acquisition_E_vF

2022.04.04

20220404_Metcela_JRM Acquisition_E_vF | Metcela Inc. | Revolutionizing the Way We Treat Heart Failure

20220404_Metcela_JRM Acquisition_E_vF

NEWS

2023.12.06

Metcela to Strengthen Clinical Pipeline Development, New Headquarters and R&D Center at Kawasaki King Skyfront
PRESS RELEASE

2023.09.21

Metcela and Nagoya University to Collaborate in Research to Accelerate the Development of Regenerative Medicine
NEWS

2022.12.08

Metcela Received the Best Research Award at the Well-being & Age-Tech 2022 Award
PRESS RELEASE

2022.11.15

Metcela eligible to receive up to $7 Million (1 Billion JPY) AMED Grant for Promoting the Development of Regenerative Medicine Product Using Cardiac Stem Cells

News archive